OREANDA-NEWS. July 26, 2010. Ingosstrakh entered into a voluntary medical insurance contract for the employees of a pharmaceutical company Glenmark Impex. 154 employees of the company and their relatives and children have been insured.

The insured amount for one insured employee according to the programs Polyclinic (classic) and Polyclinic Assistance in Russia, Specialized Dentistry, Planned and Emergency In-Patient Services and Emergency In-Patient Services in Russia is 2 mln, 1 mln and 5 mln respectively.

Insurance programs provide medical services in such medical institutions as LMS Clinic (Bud Zdorov), Central polyclinic of Literature fund, Polyclinic No3 of Russian Academy of Sciences Central Hospital, Federal State Institution Medical Unit Centromed of Minpromenergo of Russia, Federal State Institution 9th Diagnostic and Treatment Center of the Ministry of Defence of Russia (branch), network of dentistry clinics LIK, Federal State Institution Central Hospital and Polyclinic of the Russian President Affairs Management, Federal State Institution Diagnostic and Treatment Center of the Federal Agency for Public Health and Human Services, Federal State Institution Pirogov National Medico-surgical Center and others.

Ingosstrakh started cooperation with Glenmark Impex in the sphere of voluntary medical insurance in 2009.

Glenmark is one of the most dynamically developing international pharmaceutical companies with its registered address in Mumbai. The Company was established in 1977. The main spheres of activity are:

elaboration and production of finished pharma products. Main segments of activity: dermatology, pulmonology, gynecology, metabolic diseases, oncology, gastroenterology.

production of ingredients

elaboration of innovation products. Currently 7 innovation molecules (for treatment of spasmodic asthma, diabetes of the II type, fatness, central nervous system diseases, central non-opioid analgesic etc) are at the stage of clinical researches.